Type 2 & other diabetes

Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study

Diabetes Obes MetabPublished Target trial emulation study

Authors' conclusion

For T2D patients with a calculated 10-year CVD risk of less than 20%, the interval of regular physician encounters can be optimized from 2-3 to 4-6 months without compromising patients' long-term outcomes and saving substantial service resources in primary care.

Study context

Population
T2D patients without prior cardiovascular disease (CVD) and with predicted 10-year CVD risk <20%, Hong Kong public primary care
Participants
42,154 matched individuals
Comparison
Physician-encounter interval 4-6 months vs 2-3 months
Outcome
CVD incidence
Follow-up
Up to 12 (average: 5.1) years
Methodological detailspropensity-score matched, marginal structural model, territory-wide electronic medical records
  • Propensity-score matched
  • Marginal structural model
  • Territory-wide electronic medical records

Main finding

As reported in the abstract

CVD · up to 12 (average: 5.1) years
Each group vs 2-3 monthsHazard ratio (95% CI)
4-6 months
1.01(0.90–1.14)
Each group vs 2-3 monthsStandardized 10-year risk difference (95% CI)
4-6 months
−0.1%(−0.7% to 0.6%)

Further findings

OutcomeHR (CI)
All-cause mortality4-6 monthsvs 2-3 months1.00 (0.84–1.20)
OutcomeStandardized 10-year risk difference (CI)
All-cause mortality4-6 monthsvs 2-3 months−0.1% (−0.5% to 0.3%)

Secondary and tertiary care utilization; key clinical parameters (HbA1c, blood pressure, cholesterol)

No observable difference between the two follow-up frequencies

Original publication

Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study. Diabetes Obes Metab. Published 29 August 2024. doi:10.1111/dom.15899

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.